Checkpoint Therapeutics (CKPT) Stock Chart & Stock Price History $3.98 +1.51 (+61.13%) Closing price 04:00 PM EasternExtended Trading$3.97 -0.01 (-0.35%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Checkpoint Therapeutics Stock Price Performance 5 Day Performance+62.05%1 Month Performance+24.92%3 Month Performance+2.67%6 Month Performance+88.55%Year-To-Date Performance+26.09%1 Year Performance+88.99% Receive CKPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Remove Ads CKPT Stock Chart for Monday, March, 10, 2025 CKPT Chart by TradingViewRemove Ads Checkpoint Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/07/2025$2.38$2.47+3.78%$2.52$2.37619,382 shs$120.62 million03/06/2025$2.49$2.38-4.42%$2.55$2.37883,167 shs$116.22 million03/05/2025$2.63$2.49-5.32%$2.63$2.43628,629 shs$121.59 million03/04/2025$2.57$2.63+2.33%$2.68$2.43668,213 shs$128.43 million03/03/2025$2.86$2.57-10.14%$2.86$2.53968,544 shs$125.50 million02/28/2025$2.71$2.86+5.54%$2.89$2.64799,519 shs$139.66 million02/27/2025$2.78$2.71-2.52%$2.89$2.71436,926 shs$132.34 million02/26/2025$2.80$2.78-0.71%$2.85$2.76590,998 shs$135.76 million02/25/2025$2.95$2.80-5.08%$2.97$2.76654,481 shs$136.73 million02/24/2025$3.13$2.95-5.75%$3.23$2.94758,549 shs$144.06 million Get the Latest News and Ratings for CKPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/21/2025$3.18$3.13-1.57%$3.24$3.11613,012 shs$152.84 million02/20/2025$3.18$3.18$3.20$3.10358,070 shs$155.28 million02/19/2025$3.26$3.18-2.30%$3.30$3.16380,159 shs$155.28 million02/18/2025$3.31$3.26-1.66%$3.43$3.18656,333 shs$158.94 million02/17/2025$3.31$3.31$3.39$3.21731,446 shs$161.63 million02/14/2025$3.46$3.31-4.34%$3.39$3.21731,446 shs$161.63 million02/13/2025$3.35$3.46+3.28%$3.51$3.32536,319 shs$168.95 million02/12/2025$3.13$3.35+7.03%$3.42$3.09774,227 shs$163.58 million02/11/2025$3.23$3.13-3.10%$3.20$3.02851,190 shs$152.84 million02/10/2025$3.29$3.23-1.82%$3.34$3.14767,709 shs$157.73 million Related Companies Precigen Stock Chart Cullinan Therapeutics Stock Chart GH Research Stock Chart Ginkgo Bioworks Stock Chart Chimerix Stock Chart Mind Medicine (MindMed) Stock Chart ABIVAX Société Anonyme Stock Chart AnaptysBio Stock Chart Autolus Therapeutics Stock Chart Cartesian Therapeutics Stock Chart Receive CKPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CKPT) was last updated on 3/10/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThis Crypto Is Set to Explode in FebruaryA little-known IRS loophole has been gaining serious attention... If you have a retirement account, you can...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredForget Trump’s Tariffs, This March Event Is BiggerWhile everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...Brownstone Research | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Checkpoint Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Checkpoint Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
